Paul Peter Tak, MD, PhD, FMedSci
Dr. Tak is a world-renowned immunologist, drug developer, pharmaceutical CEO and entrepreneur with over 25 years of experience in the pharmaceutical industry, ranking #150 in the 2022 Edition of the World Ranking of Top 1000 Scientists in the area of Immunology. He is currently President, CEO, and Board Director of Candel Therapeutics and sits on the board of several biotech companies.
In addition to serving as Professor of Medicine and Chair of the Department of Clinical Immunology and Rheumatology at the Academic Medical Centre/University of Amsterdam (AMC), Dr. Tak was Clinical Associate Professor of Medicine at the University of California San Diego. He also served as Senior Vice President, Chief Immunology Officer, and Global Development Leader at GlaxoSmithKline (GSK). He is a co-founder of Sitryx, and was previously President and CEO of Tempero Pharmaceuticals, and Venture Partner at Flagship Pioneering.